Vitamin E, Type 2 Diabetes and Reduced Risk of Heart Attack, Stroke and Cardiovascular Death

3/1/2009

Vitamin E may be very beneficial for individuals with type 2 diabetes (DM) and the Haptoglobin 2-2 genotype (Hp2-2). People with type 2 diabetes and this genotype are 2 to 5 times more likely to suffer from cardiovascular events - heart attack, stroke, and cardiovascular death compared with other individuals with type 2 diabetes.

Researchers believe that these people have higher levels of oxidative stress and benefit from the antioxidant effects of vitamin E.

Evaluating data from an earlier vitamin E study, researchers found that vitamin E supplements significantly reduced heart attacks and cardiovascular death by 43% and 55% in people with Hp2-2 and type 2 diabetes.

The study included 1,424 individuals (aged 55 and older) and was concluded after 18 months. The researchers found that 50% of the people recruited for the study with type 2 diabetes and tested for genotype, had the Hp2-2 genotype.

Milman and others. "Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals with Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype." Arterioscler Thromb Vasc Biol., 2008;28:341-347.

Return to Newsletter Archive

Disclaimer: The statements and information upon this website have not necessarily been evaluated by the Food and Drug Administration. The products featured are not intended to diagnose, treat, cure or prevent any disease. Consumers should always consult their own medical practitioner(s) with any medical or health concerns before starting any new diet, product or supplement.